Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$230.4M
+26.3% from 2023
Prescriptions
20K
$11,545.98 per claim
Patients
1,268
657 prescribers
Total spending, 2024
$230.4M
$181,721.69 per patient
Medicare prescription drug plans paid $230.4M for Orenitram Er in 2024, for 19,957 prescriptions and refills to 1,268 patients (up 26.3% from 2023). The average cost per claim was $11,545.98.
Florida had the highest Medicare cost for Orenitram Er in 2024: $21.3M for 1,858 claims, followed by New York ($20.0M).
Eric G Roberts, advanced heart failure and transplant cardiology in Milwaukee, WI, had the highest Medicare cost for Orenitram Er in 2024: 560 claims costing $7.5M.
Orenitram Er is made by United Therapeutics Corporation (UTHR), listed in the Medicare spending data as United Therap.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Eric G Roberts Milwaukee, WI | Advanced Heart Failure and Transplant Cardiology | 560 | 30 | $7.5M |
| John Kingrey Oklahoma City, OK | Pulmonary Disease | 378 | 21 | $5.3M |
| Michael J Cuttica |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 613 | 17,178 | 1,104 | $162.2M |
| 2023 | 588 | 16,073 | 1,010 | $182.5M |
| 2024 | 657 | 19,957 | 1,268 | $230.4M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Critical Care (Intensivists) |
| 223 |
| 16 |
| $4.9M |
| R J White Rochester, NY | Pulmonary Disease | 224 | 15 | $4.8M |
| Jimmy S Smith Lexington, KY | Critical Care (Intensivists) | 131 | Under 11 | $2.9M |
| Murali M Chakinala Saint Louis, MO | Pulmonary Disease | 165 | Under 11 | $2.8M |
| James P Gagermeier Maywood, IL | Pulmonary Disease | 40 | Under 11 | $2.4M |
| Frank Cefali New York, NY | Nurse Practitioner | 193 | 11 | $2.2M |
| Janet B Pinson Richmond, VA | Nurse Practitioner | 48 | Under 11 | $2.2M |
| Mona Vashi Chicago, IL | Pulmonary Disease | 168 | 11 | $2.2M |
| Daniel J Lachant Rochester, NY | Pulmonary Disease | 83 | Under 11 | $2.2M |
| Anjali Vaidya Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 97 | Under 11 | $2.1M |
| Daniel G Gorbett Jr. Dublin, OH | Pulmonary Disease | 87 | Under 11 | $2.1M |
| Roberto F Machado Indianapolis, IN | Pulmonary Disease | 172 | 13 | $2.0M |
| Lori G Reed Marietta, GA | Nurse Practitioner | 118 | Under 11 | $2.0M |
| Ricardo Restrepo-Jaramillo Tampa, FL | Pulmonary Disease | 206 | 13 | $2.0M |
| Sandeep Sahay Houston, TX | Pulmonary Disease | 133 | Under 11 | $2.0M |
| Carlton G Cauthen Columbia, SC | Pulmonary Disease | 55 | Under 11 | $1.9M |
| Jamey J Ruiz Maumee, OH | Pulmonary Disease | 186 | Under 11 | $1.9M |
| Franck F Rahaghi Weston, FL | Pulmonary Disease | 114 | 11 | $1.7M |
| Sophy Dedopoulos New Hyde Park, NY | Nurse Practitioner | 189 | 15 | $1.7M |
| Imad S Farrukh West Jordan, UT | Pulmonary Disease | 125 | Under 11 | $1.5M |
| Elie L Homsy Columbus, OH | Pulmonary Disease | 117 | Under 11 | $1.5M |
| Sunil Pauwaa Oak Lawn, IL | Advanced Heart Failure and Transplant Cardiology | 99 | Under 11 | $1.4M |
| Veronica Franco Columbus, OH | Advanced Heart Failure and Transplant Cardiology | 53 | Under 11 | $1.4M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| United Therap UTHR | 19,957 | $230.4M |